Ralinepag Phase II Open-Label Extension Study in Patients with Pulmonary Arterial Hypertension
Article in Advances in Therapy (January 2024)
The most recent citing publications are shown below. View all 56 publications that cite this research output on Dimensions.
Use of the National Cancer Institute Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events to assess treatment tolerability in pulmonary arterial hypertension: qualitative patient research findings in current and former users of oral selexipag
Article in Journal of Patient-Reported Outcomes (December 2023)
Intratracheally Administered Peptide-Modified Lipid Admixture Containing Fasudil and/or DETA NONOate Ameliorates Various Pathologies of Pulmonary Arterial Hypertension
Article in Pharmaceuticals (November 2023)